Tenax Therapeutics, Inc. (TENX) stock
TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.25−0.14 (-10.07%)
Close on Nov 20, 2026Market cap $46.78MP/E –Yield –
Tenax Therapeutics gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Tenax Therapeutics's gross profit for the twelve months ending Apr 30, 2015 was $0. For fiscal 2015 it was $0. The highest annual figure on record is $103.17K in fiscal 2011.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2015 | Apr 30, 2015 | $0 | – |
| FY2014 | Apr 30, 2014 | -$104.07K | -309.9% |
| FY2013 | Apr 30, 2013 | $49.57K | +0.6% |
| FY2012 | Apr 30, 2012 | $49.27K | -52.2% |
| FY2011 | Apr 30, 2011 | $103.17K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2015CQ1 2015 | Apr 30, 2015 | $0 | – |
| Q3 FY2015CQ4 2014 | Jan 31, 2015 | $0 | – |
See a number that looks wrong?